Conversely, patients with intermediate/poor cytogenetics had decreased PI of non-lymphoid CD34+ and NRBC vs. both normal/reactive BM (p≤0.002) and MDS cases with normal/favourable cytogenetics (p = 0.01) (Table 3). Here, CD34 is linked to myelodysplastic syndrome.